HIV Infections
📧 Sign up to get email alerts when something new happens for HIV Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants [Phase 1]
Phase 1 trial assessing safety and pharmacokinetics of HIV-neutralizing monoclonal antibodies VRC01, VRC01LS, and VRC07-523LS in HIV-1-expos…
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States [Phase 1]
Phase 1 clinical trial evaluating safety and immunogenicity of an HIV vaccine (gp145 C.6980) in healthy, HIV-uninfected adults in the United…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Could Dietary Algae Affect Immunity and Viral Counts in People With HIV? [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing whether dietary algae can influence immunity and viral counts in people with HIV.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy [Phase 4]
A Phase 4 clinical trial evaluating the efficacy of enfuvirtide during the induction phase of therapy for HIV infections has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected Adults [Phase 3]
Phase 3 trial update on rapid test-and-treat Dolutegravir plus Lamivudine in newly diagnosed HIV-1 adults; results posted in 2021.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) Study [Phase 1]
Phase 1 first-in-human study evaluating safety, tolerability, and pharmacokinetics of GSK3732394; the trial was terminated and results poste…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205 [Phase 1]
Phase 1 trial updating immunogenicity of AIDSVAX B/E and MVA/HIV62B vaccines in HIV-uninfected adults previously exposed to MVA/HIV62B, with…
-
CLINICAL_TRIALS trial_result · 2021-03-26Clinical Trial Update: Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E [Phase 2]
Phase 2 clinical trial update on boosting strategies after vaccination with ALVAC-HIV and AIDSVAX B/E for HIV infections.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir [Phase 2]
Phase 2 trial update on viral dynamics and pharmacokinetics of abacavir and tenofovir in HIV infections.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants [Phase 1]
Phase 1 study comparing relative bioavailability and food effects of GSK3640254 tablet and capsule in healthy participants.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and immunogenicity of ALVAC-HIV with MF59 or AS01B adjuvants in healthy, HIV-uninfected adults; s…
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults [Phase 1]
Phase 1 trial evaluating safety, pharmacokinetics, and anti-viral activity of VRC01 and VRC01LS in healthy HIV-uninfected adults with comple…
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB [Phase 1, Phase 2]
Phase 1/2 trial assessing safety, tolerance, and pharmacokinetics of raltegravir-containing ART in infants and children with HIV and tubercu…
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial investigating mitoguazone dihydrochloride in AIDS-related non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV [Phase 2]
Phase 2 trial update exploring reversing tissue fibrosis to improve immune reconstitution in HIV.
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: Kaletra and Viread in Antiretroviral Naïve Patients [Phase 4]
A Phase 4 trial update on Kaletra and Viread in antiretroviral-naïve HIV patients; the study status is TERMINATED with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Pharmacokinetics Study on Nevirapine Resistance in Tanzania [Phase 2]
Phase 2 pharmacokinetics study investigating nevirapine resistance in HIV infections conducted in Tanzania has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection [Phase 1]
Phase 1 trial assessing safety and pharmacokinetics of maraviroc in HIV-1–exposed infants at risk of acquiring HIV-1 infection has completed…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients [Phase 2]
Phase 2 pharmacokinetic study evaluating interactions between rosuvastatin and lopinavir/ritonavir in HIV patients with hyperlipidemia; comp…
-
CLINICAL_TRIALS trial_result · 2020-11-12Clinical Trial Update: Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients [Phase 4]
A Phase 4 trial update evaluating drug interaction between atovaquone and antiretroviral agents in HIV-1 infected patients completed.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: Study of Late Boost Strategies for HIV-uninfected Participants From Protocol RV 144 [Phase 2]
A Phase 2 clinical trial update evaluating late boost strategies for HIV-uninfected participants from Protocol RV 144; current status unknow…
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study) [Phase 4]
A Phase 4 trial evaluating Kaletra and Maraviroc in ART-naive HIV patients was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women. [Phase 1, Phase 2]
Phase 1/2 pharmacokinetic study of a new tablet formulation of saquinavir in HIV-infected pregnant women has completed.
-
EMA withdrawal · 2020-10-13EMA Withdrawn: Zerit (stavudine) — Bristol-Myers Squibb Pharma EEIG
EMA has withdrawn Zerit (stavudine) for HIV infections; decision dated 13 February 2019.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults [NA]
Clinical trial completed evaluating an online prevention program to reduce STD infection risk in young adults; results posted in 2020.